Platelet-monocyte aggregate formation and mortality risk in older patients with severe sepsis and septic shock

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 70, Issue 2, 2015, Pages 225-231

  Rondina, Matthew T ^a,b   Carlisle, McKenzie ^b   Fraughton, Tamra ^b,c   Brown, Samuel M ^a,d   Miller, Russell R ^d   Harris, Estelle S ^a   Weyrich, Andrew S ^a,b   Zimmerman, Guy A ^a   Supiano, Mark A ^a   Grissom, Colin K ^a,d  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Program in Molecular Medicine   (United States)

^c Department of Psychology ^*  (United States)

^d INTERMOUNTAIN MEDICAL CENTER   (United States)

Author keywords

Inflammation; Mortality; Platelet; Platelet monocyte aggregates; Sepsis

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 6; INTERLEUKIN 8;

AGED; BLOOD; CELL AGGREGATION; FEMALE; FLOW CYTOMETRY; HUMAN; INTENSIVE CARE UNIT; MALE; MONOCYTE; MORTALITY; PHYSIOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIC SHOCK; THROMBOCYTE;

AGED; BIOLOGICAL MARKERS; BLOOD PLATELETS; CELL AGGREGATION; FEMALE; FLOW CYTOMETRY; HUMANS; INTENSIVE CARE UNITS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MONOCYTES; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEPSIS; SHOCK, SEPTIC;

EID: 84922464391     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glu082     Document Type: Article

References (36)

1. Rondina MT, Schwertz H, Harris ES, et al. The septic milieu triggers expression of spliced tissue factor mRNA in human platelets. J Thromb Haemost. 2011; 9: 748-758. doi: 10.1111/j.1538-7836.2011.04208.x
2. Vieira-de-Abreu A, Rondina MT, Weyrich AS, Zimmerman GA. Inflammation. In: Michelson AD ed. Platelets. 3rd ed. New York: Elsevier; 2012: 733-766.
3. Garraud O, Berthet J, Hamzeh-Cognasse H, Cognasse F. Pathogen sensing, subsequent signalling, and signalosome in human platelets. Thromb Res. 2011; 127: 283-286. doi: 10.1016/j.thromres.2010.10.015
4. Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation. 2001; 104: 1533-1537.
5. Rondina MT, Grissom CK, Men S, et al. Whole blood flow cytometry measurements of in vivo platelet activation in critically-Ill patients are influenced by variability in blood sampling techniques. Thromb Res. 2012; 129: 729-735. doi: 10.1016/j.thromres.2011.11.031
6. Weyrich AS, Elstad MR, McEver RP, et al. Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest. 1996; 97: 1525-1534.
7. Girard TD, Opal SM, Ely EW. Insights into severe sepsis in older patients: from epidemiology to evidence-based management. Clin Infect Dis. 2005; 40: 719-727.
8. Martin GS, Mannino DM, Moss M. The effect of age on the development and outcome of adult sepsis. Crit Care Med. 2006; 34: 15-21.
9. De Gaudio AR, Rinaldi S, Chelazzi C, Borracci T. Pathophysiology of sepsis in the elderly: clinical impact and therapeutic considerations. Curr Drug Targets. 2009; 10: 60-70.
10. Baldwin MR, Narain WR, Wunsch H, et al. A prognostic model for 6-month mortality in elderly survivors of critical illness. Chest. 2013; 143: 910-919. doi: 10.1378/chest.12-1668
11. Seidler S, Zimmermann HW, Bartneck M, Trautwein C, Tacke F. Age-dependent alterations of monocyte subsets and monocyterelated chemokine pathways in healthy adults. BMC Immunol. 2010; 11: 30. doi: 10.1186/1471-2172-11-30
12. Plackett TP, Boehmer ED, Faunce DE, Kovacs EJ. Aging and innate immune cells. J Leukoc Biol. 2004; 76: 291-299.
13. Shaw AC, Goldstein DR, Montgomery RR. Age-dependent dysregulation of innate immunity. Nat Rev Immunol. 2013; 13: 875-887. doi: 10.1038/nri3547
14. Cesari M, Kritchevsky SB, Leeuwenburgh C, Pahor M. Oxidative damage and platelet activation as new predictors of mobility disability and mortality in elders. Antioxid Redox Signal. 2006; 8: 609-619.
15. Reilly IA, Doran JB, Smith B, FitzGerald GA. Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase. Circulation. 1986; 73: 1300-1309.
16. Mohebali D, Kaplan D, Carlisle M, Supiano MA, Rondina MT. Alterations in platelet function during aging: clinical correlations with thromboinflammatory disease in older adults. J Am Geriatr Soc. 2014; 62: 529-535. doi: 10.1111/jgs.12700
17. Bone RC, Balk RA, Cerra FB, et al. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992; 20: 864-874.
18. Rondina MT, Brewster B, Grissom CK, et al. In Vivo Platelet Activation in Critically Ill Patients With Primary 2009 Influenza A (H1N1). Chest. 2012, 141: 1490-1495. doi: 10.1378/chest.11-2860
19. Rondina MT, Weyrich AS, Zimmerman GA. Platelets as cellular effectors of inflammation in vascular diseases. Circ Res. 2013; 112: 1506-1519. doi: 10.1161/CIRCRESAHA.113.300512
20. Fulton RJ, McDade RL, Smith PL, Kienker LJ, Kettman JR Jr. Advanced multiplexed analysis with the FlowMetrix system. Clin Chem. 1997; 43: 1749-1756.
21. Aiken LS, West SG. Multiple Regression: Testing and Interpreting Interactions. London: Sage Publications; 1991.
22. Schmidt R, Bultmann A, Fischel S, et al. Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes. Circ Res. 2008; 102: 302-309.
23. Bozza FA, Salluh JI, Japiassu AM, et al. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care. 2007; 11: R49.
24. Johnson M, Ramey E, Ramwell PW. Sex and age differences in human platelet aggregation. Nature. 1975; 253: 355-357.
25. Sie P, Montagut J, Blanc M, et al. Evaluation of some platelet parameters in a group of elderly people. Thromb Haemost. 1981; 45: 197-199.
26. Fagiolo U, Cossarizza A, Scala E, et al. Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol. 1993; 23: 2375-2378.
27. Dreiher J, Almog Y, Sprung CL, et al.; SEPSIS-ISR Group. Temporal trends in patient characteristics and survival of intensive care admissions with sepsis: a multicenter analysis. Crit Care Med. 2012; 40: 855-860. doi: 10.1097/CCM.0b013e318236f7b8
28. Freedman JE, Loscalzo J. Platelet-monocyte aggregates: bridging thrombosis and inflammation. Circulation. 2002; 105: 2130-2132.
29. Weyrich AS, Denis MM, Kuhlmann-Eyre JR, et al. Dipyridamole selectively inhibits inflammatory gene expression in platelet-monocyte aggregates. Circulation. 2005; 111: 633-642.
30. Furman MI, Barnard MR, Krueger LA, et al. Circulating monocyteplatelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol. 2001; 38: 1002-1006.
31. Lukasik M, Dworacki G, Kufel-Grabowska J, Watala C, Kozubski W. Upregulation of CD40 ligand and enhanced monocyte-platelet aggregate formation are associated with worse clinical outcome after ischaemic stroke. Thromb Haemost. 2012; 107: 346-355. doi: 10.1160/TH11-05-0345
32. Andaluz-Ojeda D, Bobillo F, Iglesias V, et al. A combined score of pro- and anti-inflammatory interleukins improves mortality prediction in severe sepsis. Cytokine. 2012; 57: 332-336. doi: 10.1016/j. cyto.2011.12.002
33. Calfee CS, Ware LB, Glidden DV, et al.; National Heart, Blood, and Lung Institute Acute Respiratory Distress Syndrome Network. Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury. Crit Care Med. 2011; 39: 711-717. doi: 10.1097/CCM.0b013e318207ec3c
34. Leng S, Chaves P, Koenig K, Walston J. Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc. 2002; 50: 1268-1271.
35. Klinkhardt U, Bauersachs R, Adams J, Graff J, Lindhoff-Last E, Harder S. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease. Clin Pharmacol Ther. 2003; 73: 232-241.
36. Leng S, Xue QL, Huang Y, et al. Total and differential white blood cell counts and their associations with circulating interleukin-6 levels in community-dwelling older women. J Gerontol A Biol Sci Med Sci. 2005; 60: 195-199.